New Hope for a “Cursed” Crop? Understanding Stakeholder Attitudes to Plant Molecular Farming With Modified Tobacco in Europe by Menary, J et al.
fpls-11-00791 June 11, 2020 Time: 21:24 # 1
ORIGINAL RESEARCH




Virginia Tech, United States
Reviewed by:
Johannes Felix Buyel,
Fraunhofer Institute for Molecular
Biology and Applied Ecology,
Fraunhofer Society (FHG), Germany
Eva Stoger,
University of Natural Resources





This article was submitted to
Plant Biotechnology,
a section of the journal
Frontiers in Plant Science
Received: 12 February 2020
Accepted: 18 May 2020
Published: 12 June 2020
Citation:
Menary J, Amato M, Sanchez AC,
Hobbs M, Pacho A and Fuller SS
(2020) New Hope for a “Cursed”
Crop? Understanding Stakeholder
Attitudes to Plant Molecular Farming
With Modified Tobacco in Europe.
Front. Plant Sci. 11:791.
doi: 10.3389/fpls.2020.00791
New Hope for a “Cursed” Crop?
Understanding Stakeholder Attitudes
to Plant Molecular Farming With
Modified Tobacco in Europe
Jonathan Menary1, Mario Amato2, Andrés Cid Sanchez3, Matthew Hobbs1,
Agata Pacho1 and Sebastian S. Fuller1*
1 Institute for Infection and Immunity, St George’s, University of London, London, United Kingdom, 2 Department of Political
Science, University of Naples Federico II, Naples, Italy, 3 Department of Microbiology, Centro Technológico Agroalimentario
Extremadura (CTAEX), Badajoz, Spain
Plant molecular farming (PMF) with tobacco could provide a sustainable and cheap
platform for the production of high-value proteins for medical use. It could also offer
European tobacco farmers an alternative, healthful end use for their crop. New plant
breeding techniques (NPBTs) offer a means of quickly and precisely optimizing molecular
farming platforms for this purpose. However, there has been little empirical research
focussing on the barriers and facilitators of these technologies in the agricultural sphere.
Here, we explore key stakeholder perceptions toward this combination of technologies,
exploring their understanding of risk and opportunity. We interviewed N = 24 key
stakeholders – tobacco farmers, agronomists, policymakers, and researchers – in three
tobacco-growing areas of Spain and Italy. Our findings demonstrate these stakeholders
have a favorable attitude toward PMF with tobacco due to its beneficial medical
purpose and the opportunity it provides farmers to continue growing tobacco in a
declining European market. Tobacco producers also reported favorable views toward
NPBTs, though for some this was contingent on their use for non-food crops like
tobacco. Most stakeholders’ concerns are economic in nature, such as potential
profitability and demands for new agronomic practices or infrastructure. Tobacco
producer associations were thought to be important facilitators for future PMF scale-up.
The attitude toward these technologies by smoking tobacco companies is, however,
unknown and constitutes a potential risk to the development of PMF.
Keywords: plant molecular farming, pharming, new plant breeding techniques, qualitative research, responsible
research and innovation, tobacco
INTRODUCTION
Plant molecular farming (PMF) produces high-value molecules in plants. These include proteins
for medical use (Ma et al., 2005, 2015; Teh et al., 2014; van Dolleweerd et al., 2014; Budzianowski,
2015; De Martinis et al., 2016; Dhama et al., 2018) and secondary metabolites for a variety of
uses, such as industrial enzymes and cosmetic products (Tschofen et al., 2016). Demand for these
molecules has grown and continues to rise, sometimes outstripping supply from existing protein
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expression systems that rely on yeast, bacterial, and mammalian
cell cultures (Obembe et al., 2011; van Dolleweerd et al., 2014).
Plants are an attractive alternative to these expression systems due
to their potential for: (i) lower up-front production costs; (ii) low
risk of contamination with human pathogens; (iii) scalability of
cultivation; and (iv) expertise and infrastructure in place for the
production of plant material (Horn et al., 2004; Twyman et al.,
2005; Ma et al., 2013; Xu and Zhang, 2014; Tschofen et al., 2016).
It has been noted that the scale-up of PMF could represent a
significant boost to global health (Paul et al., 2011; Buyel et al.,
2017). Currently, PMF research is being carried out in North and
South America, Europe, Japan, China, Thailand, Australia, and
South Africa (De Martinis et al., 2016; Murad et al., 2020).
PMF represents the “third” generation of biotechnology
(Sakakibara and Saito, 2006) and new plant breeding techniques
(NPBTs) – a suite of technologies that allow the precise
modification of plant germlines – can improve PMF platforms
for better expression of target proteins (Mercx et al., 2016).
NPBTs include site-specific nucleases, such as CRISPR Cas-
9, which can induce precise, single base-pair modifications to
plant genomes. Whilst certain biopharmaceutical PMF involve
the use of transgenes, “gene editing” makes possible vertical
cisgenic or intragenic changes in plant genomes (i.e., using
only the “native” genetics of a plant in natural or novel
combinations). NPBTs have renewed the debate on how best to
regulate plant breeding technology, particularly in Europe where
public reaction to genetically modified (GM) crops has been
both pronounced and instrumental in shaping biotechnological
trajectories (Ma et al., 2005; Hartley et al., 2016; Malyska
et al., 2016; Tanaka, 2017; Pei and Schmidt, 2019). Current
European Union (EU) regulation dictates that plants bred
through the use of NPBTs are considered GM crops, even if
the resultant plant line contains no transgenes (Eckerstorfer
et al., 2019). The 2018 decision of the European Court of
Justice on this matter has caused concern amongst scientists
over the future of European biotechnology investment and the
ability of existing systems to effectively monitor such organisms
(Wight, 2018; Ledford, 2019). The risks of biotechnology have
often been understood in terms of potential environmental
or human health hazards; yet risk must be weighed against
opportunity, which can be defined as the potential benefits
of a technology (Raybould and Macdonald, 2018). However,
what constitutes risk and opportunity is not always clear. Some
authors have argued that perceptions of risk are shaped by
local social factors and that these social understandings of risk
must be explored for a true accounting of technological risk
(Guehlstorf, 2008; Pavone et al., 2011; Binimelis and Myhr,
2016). NPBTs (and PMF) could change our understanding of
the ethical implications, risk and opportunity of biotechnology
due to its potential to confer consumer or social benefit
(Nevitt et al., 2006), whilst being closer to the conventional
breeding practices farmers have traditionally employed (Malyska
et al., 2016). Some authors have also noted that understanding
farmers’ opinions toward biotechnology could provide a “middle
ground” between advocates of biotechnology and its opponents,
arguing that because farmers will continue to face choices about
biotechnology policy planners should have an understanding
of the demand for GM crops amongst key stakeholder groups
(Guehlstorf, 2008).
The use of crop plants for PMF bridges both the agricultural
and health sciences, which have distinct processes of
implementing research into practice (Menary, 2015). When it
comes to understanding the adoption of agricultural technology
or practices, studies range in scope from the local and specific
(D’Emden et al., 2008; Howell et al., 2015; Aryal et al., 2018),
to the broad and general (Pierpaoli et al., 2013; Kuehne et al.,
2017). Some focus on behavioral characteristics of farmers in the
adoption of new practices (Dessart et al., 2019) and others on
characteristics of the practice or technology itself (Kuehne et al.,
2017). These studies often rely on quantitative methodologies,
particularly surveys and econometric approaches, in order to
identify patterns of adoption and make predicative models for
the spread of new agricultural technologies.
Rather than see farmers as passive adopters of biotechnology,
though, other frameworks see them as vital components
of the innovation process itself. The agricultural innovation
systems framework (AIS) emphasizes the importance interaction
amongst farmers, researchers, agronomists, input suppliers, and
policymakers for innovation (Rajalahti et al., 2008; Klerkx
et al., 2010). These interactions are in turn shaped by relevant
institutional and policy environments, which often require
social innovation to permit technological change or improved
agricultural practices (Turner et al., 2017). Howell et al. (2015),
for example, demonstrate that farmers in Nepal were unlikely
to adopt improved water management techniques due to local
institutional factors. Innovation is therefore often cast as the co-
evolution of social and technological systems (Schut et al., 2015).
Recent literature has also explored “transitions,” that is, the
wider changes in the socio-technical regime as society and
technology develop (Geels, 2010). The multi-level perspective
describes a number of levels – niches (where radical innovation
emerges), the socio-technical regime (current ways of doing
things that are stabilized through behavior, vested interests and
existing regulations) and the socio-technical landscape (the slow-
changing exogenous environment) – that can be used to explain
the gradual development of PMF in Europe. Menary et al. (2020)
describe how the existing socio-technical regime has been one
of several factors constraining PMF; existing regulations do not
reflect the advantages offered by plants and significant investment
in cell culture alternatives by pharmaceutical companies deters
investment in plant-made alternatives.
For these systems-based approaches it is necessary to
understand local conditions, policies and issues for key
stakeholders. We argue that this is no less true for open-field
PMF. A number of studies have focussed on such contexts,
predominantly in United States tobacco-growing regions, where
since the early 2000s the idea of substituting traditional smoking
tobacco for PMF tobacco has gained attention (Nevitt et al., 2006,
2003; Hayes et al., 2014). These studies concern first-generation,
transgenic PMF tobacco; none have yet explored the development
cisgenic or intragenic PMF tobacco, for example, nor the prospect
of PMF in Europe. As such, there is a need to explore the
perceptions of risk and opportunity amongst key stakeholders
and understand the potential barriers and facilitators for the
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responsible scale-up of PMF. Recent studies have also highlighted
the need for consultations with producers and end-users in the
development and governance of science and innovation, such
as called for under the Responsible Research and Innovation
(RRI) framework, the principles of which are encompassed in
the Horizon 2020 programme (Stilgoe et al., 2013; Loureiro
and Conceição, 2019). There is a need to understand how the
biotechnology that makes PMF possible will be perceived by
its potential stakeholders and how this technology could be
implemented in the European context.
The Newcotiana project1 is funded by the European
Commission Horizon 2020 programme and led by Consejo
Superior de Investigaciones Científicas (CSIC) in Spain, involving
18 institutions in EU member states and one in Australia.
The programme of work focuses on the application of NPBTs
to improving the tobacco plant (N. tabacum) and a closely
related cousin (N. benthamiana) as PMF platforms. The tobacco
plant has been used as a model crop for a number of
decades and became the first transgenic plant in the early
1980s. N. benthamiana is used for similar purposes and has
recently been used in the transient (i.e., temporary) expression
of antibodies for HIV treatment (Lombardi et al., 2009; Teh
et al., 2014). These plants have been described as the “white
mice” of the plant kingdom (Nevitt et al., 2003). Alongside
product-focused targets, generic crop improvements, such as
various stress tolerances and the suppression of flowering are also
planned. Non-flowering traits are a biosafety feature intended
to prevent outcrossing with other crops. Coupled with stagnant
or declining tobacco production in some EU member states
(European Commission, 2015), PMF tobacco could also offer
producers a new and more profitable end use for their crop.
The gradual substitution of tobacco for other crops has also
been promoted through reforms to the Common Agricultural
Policy (CAP) in recent years (Geist et al., 2009). Likewise,
the EU’s “Bioeconomy Strategy” promotes the development of
“greener,” more sustainable and circular industrial processes
(European Commission, 2018). PMF could represent a valuable
contribution to those aims.
Important questions remain over the reliability and safety of
plant-derived molecules, particularly where these are intended
for medical use (Ma et al., 2015). Open-field PMF presents
a number of additional challenges in this respect, such as
the uniformity of plants grown under changeable cultivation
conditions and the risk of contamination, both in terms of the
molecules themselves and the unwanted spread of GM plants
(Mascia and Flavell, 2004; Breyer et al., 2009). Whether open-
field PMF for biopharmaceuticals can ever meet the strict criteria
laid out in good manufacturing practice guidelines has been
questioned by leading PMF scientists (Menary et al., 2020).
However, the development of enriched, open-field Newcotiana
N. tabacum feedstock lines that are intragenic (i.e., containing
novel combinations of native genetics but no transgenes) and
destined for biorefinery use is intended to be a “proving ground”
for the efficacy of NPBTs in Europe and a means to demonstrate
the reliability of PMF platforms.
1https://newcotiana.org
Here we present the findings from our interviews with key
stakeholders in the tobacco farming industry on their opinions
toward PMF and NPBTs.
MATERIALS AND METHODS
Our study employed semi-structured interviews to generate
qualitative data (62), which were chosen to probe perceptions of
risk and opportunity around new technology and the systemic
factors that influence the tobacco supply chain as it exists today
and could exist for PMF tobacco.
Following previous research that explored the perceptions of
Newcotiana consortium researchers and businesses toward the
barriers and facilitators of PMF and NPBTs (Menary et al., 2020),
relevant key stakeholders in the production and distribution of
tobacco were hypothesized to be existing tobacco farmers, their
advisors and producer associations, as well as policy makers
and researchers familiar with tobacco production. Onward
supply chain stakeholders such as pharmaceutical companies and
regulators are being queried in other Newcotiana work packages.
Our selection criteria for study sites were: (1) sites should be in
countries with large-scale tobacco production in the EU and (2)
study sites should represent major tobacco growing areas within
those countries.
An interview guide was designed to probe: (i) participants’
involvement in tobacco production, (ii) challenges for modern
tobacco production, (iii) participants’ attitudes toward new
end uses for tobacco, (iv) perceptions of genetic modification
and NPBTs, (v) and potential barriers to up-scaling PMF in
their communities and countries (see Supplementary Material).
The participant information sheet detailed the aims of the
project and the reason for participants’ involvement. The
information sheet was available in the predominant local
language and consent was given by all participants in advance
of the interviews. Interviews were conducted by JM, a PhD-
level social scientist with 6 years of experience in qualitative
research. Additionally, to ensure we could interview participants
in the language they were most comfortable, we employed a
quasi-peer interviewer technique in which researchers MA
(Italian) and AS (Spanish) facilitated interviews alongside
JM. MA is a research fellow at University of Naples Federico
II and AS is a biologist with Newcotiana partner institution
CTAEX. No relationships existed between interviewer(s)
and participants prior to the study. However, gatekeepers
(contacts at tobacco producer associations) purposively
selected people who they knew to be members of the
professional tobacco growing community in that area to
invite to interview.
Data Analysis
Interviews were fully translated and transcribed into English
using a professional translation and transcription service and
were then checked for accuracy by the relevant interviewers (JM,
MA, and AS). Any identifying information of participants was
removed. The transcripts were uploaded into NVivo 12 for data
management and analysis.
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Data analysis was undertaken in accordance with Framework
Analysis, a thematic approach for large-scale policy work (Ritchie
and Lewis, 2010). It is designed for instances in which there are
specific questions, a pre-designated sample (often professionals
in a given domain), limited timeframes and known a priori issues
(Srivastava and Thomson, 2009). An initial coding framework
was developed for the interviews conducted in Italy by JM, SSF,
MH, and AP. SSF and AP are both PhD-level social scientists
with >10 years’ experience with qualitative data collection
and analysis; MH is a social science research assistant with 2
years’ of experience. The researchers then checked the Spanish
interview transcripts against this coding framework, judging as a
group many of the same themes to be present in both datasets
with minimal need for refinement. Subsequent indexing was
undertaken by JM using NVivo 12.
St George’s University of London ethical review committee
gave approval for this study (reference: SGREC18.0006).
FINDINGS
Four countries were considered for inclusion: Greece, Italy,
Poland, and Spain. Contact was made with gatekeepers
(researchers and tobacco producer associations) in these areas,
with Italy (Campania) and Spain (Extremadura) being chosen as
suitable study locations on the basis that our study site selection
criteria were met and that interviews could be arranged with a
variety of individuals associated with tobacco production (see
Figure 1). Spain and Italy together represent ∼40% of EU tobacco
production (63).
In total, N = 24 interviews were undertaken at three sites
(two in Campania and one in Spain) between November 2018
and February 2019 – 15 were with tobacco producers, seven
with tobacco technicians2, one with a policy expert and one with
2Technicians advise tobacco farmers on what plant varieties to use given the
characteristics of their land, what plant protection products to use and agronomic
advice. They are typically employed by POs.
FIGURE 1 | A map of Western Europe showing Extremadura (Spain) and
Campania (Italy).
a researcher specializing in (tobacco) agricultural engineering.
Five participants represented two categories, the most common
pairing being farmer and technician. The majority of participants
(n = 20) were male. Interviews lasted between 25 and 55 min
and took place in the offices of the local producer associations.
Interviews were recorded by Dictaphone and field notes were
made by the research assistant (JM) during and after the
meetings. MA and AS helped organize the meetings, translate
questions and answers, review interview transcripts and the
initial analysis. A unique participant number is used following
quotations used below.
Tobacco Production in Campania and
Extremadura
Tobacco was first introduced to Italy in the sixteenth Century.
Today, Italy is the EU’s largest producer of tobacco. Over 50,000
tons are produced each year, the primary locations for tobacco
production being Veneto, Umbria, Tuscany, and Campania
(Martino et al., 2014). Campania is a region in southern Italy.
Most tobacco is grown to the north on a flat plain around
Caserta and north-east in the Apennine area near the town of
Benevento. The only variety of tobacco grown in Campania is
Burley (“Kentucky”) tobacco, which is used in “Toscano” cigars
(Raimo et al., 2016).
The average tobacco farm in Campania represented in the
present sample (n = 8) is 7.3 ha, the smallest being 4 ha
and the largest being 10 ha (with a standard deviation of 1.8
ha). These were self-reported figures of tobacco-growing area
only. It should also be noted that many tobacco producers
have other holdings, but reserve land for cereals (primarily
wheat), olives, and vegetables. Most tobacco farms in the area
are family farms organized as independent businesses that are
affiliated to one of several producer associations in the area. These
organizations facilitate several activities on behalf of tobacco
farmers3, such as contract negotiation, providing loans for
infrastructure and machinery and agronomic advice throughout
the growing cycle. Approved seed is distributed either through
producer associations or through local producers under license
[several of the participants in the study grew seed on behalf of
Philip Morris International (PMI)]. Seed is raised under cover in
polytunnels or glasshouses before being transplanted to the field.
A team of workers (sometimes including the farmer’s family)
harvest the tobacco leaves three to four times between July and
early September; the hand-picked leaves are strung together then
hung to (air) dry before being manually sorted and boxed.
Industrial-scale tobacco production began in Extremadura
following the “internal colonization” policies of the Franco era,
which established rural communities in newly irrigated dry
regions (Naylon, 1967). Today, Spain produces 32,000 tons of
tobacco, predominantly in the region of Cáceres, close to the
Tiétar River and at the foot of the Sierra de Gredos. The Virginia
(bright-leafed) variety of tobacco is grown in Extremadura at
scales considerably larger than in Campania, as this crop can
be mechanically harvested. The average size of tobacco farms
in Extremadura represented in the present sample (n = 8) is
3Producers in the EU must belong to an association in order to grow tobacco.
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46.4 ha, the smallest being 10 ha and the largest 92 ha (with a
standard deviation of 34 ha). These were self-reported figures
of tobacco-growing area only. As in Campania, most tobacco
producers also reserved sizable portions of their land for other
crops, including cereals (primarily maize), soft fruit and chili
peppers. Most farms are family owned but affiliated with one of
three large producer associations in the area. These associations,
however, also manage communal flue drying facilities (available
for use among association members), as Virginia tobacco is dried
in bulk. The associations sort and box the tobacco on behalf of
their members before sale to Deltafina, a subsidiary of Universal
Corporation, which supplies Altria and PMI.
Current Challenges in Tobacco
Production
Our participants reported a range of challenges for tobacco
production in their respective countries, the most significant
being stagnant prices paid for the crop and rising costs of
production. In Spain, producers claimed that due to CAP reform,
tobacco had become unprofitable and is sold at below market
rates – yet government subsidies have meant that tobacco
production can continue. Many producers have turned to other
crops to supplement their income (though one participant had
recently given up on tobacco altogether, citing falling profitability
as the primary reason).
A key concern for producers is the availability and proficiency
of farm workers, who have become harder to find in recent years
due to the physical difficulty of the work involved and reliance
on a diminishing number of migrant workers. As one Spanish
producer noted: “Until this year, we have worked with foreign
workers. But already this year we had some difficulties. . . you
don’t find foreign workers anymore” (Participant 16).
The producers also spoke of the social stigma associated
with tobacco, one declaring that “the crop is cursed.” Although
many described feeling stigmatized, none had experienced an
outward manifestation of stigma from members of the public.
Participants described feeling that campaigns against smoking
were a challenge to their livelihoods: “. . . because there are
worldwide anti-smoking campaigns, you are affected, even as a
producer” (Participant 24). Some were more defensive, arguing
that it remains legal to produce tobacco (they are “not producing
smokers” or “killing anybody,” after all) and that farmers of
other crops, such as wine grapes, are rarely accused of producing
“alcoholics” in the same way tobacco producers are associated
with the users of their product. A participant with significant
holdings in Spain called for tobacco production to be banned
outright rather than be “strangled” by low prices and dependence
on subsidy (they did not see themselves abandoning tobacco
for any other reason). These views point to a strong sense of
identity as tobacco producers, caught between their traditional
way of life (many were second- or third-generation tobacco
producers farming family land), social pressure and difficult
economic circumstances.
The impacts of climate change were cited as a significant
problem for producers and technicians. Several participants
described more extreme weather: “I remember when I was a
kid I used to go to the fields and there was a lot of dew,
wetting your shoes until 10, 11 in the morning. Now it’s like
the desert” (Participant 19). Other environmental factors, such as
pests, were also a source of concern. The main pests (according
to participants) are tobacco flea beetle (Epitrix hirtipennis),
nematodes and downy mildew (Peronospora). A variety of
phytosanitary measures exist for the control of these pests, but
the withdrawal of particular active ingredients in recent years
within the EU has led to less effective pest control: “. . . in
terms of plagues and diseases, many chemical products are
disappearing, many active [ingredients] are being regulated.
So we have to search for other means of controlling those”
(Participant 2). In order to overcome the challenge of shrinking
chemical portfolios, technicians spoke of collaborating with local
agricultural administrations and private companies to explore
alternative pest control options. Experimentation was a recurrent
theme amongst producers and technicians alike: “I have already
cooperated in the past with the University of Naples for studies
on phytosanitary products” (Participant 15). Another producer
described devoting a two-and-a-half hectare area of his growing
area to trialing different varieties of tobacco.
New End Uses for Tobacco
As described above, tobacco producers saw themselves as the
farmers of a crop and not, as stigma around tobacco might
suggest, the growers of illicit substance. The end-use of their
crop did not personally concern them in most cases, though
the prospect of a more healthful purpose for tobacco was,
conversely, described in strong terms: “. . . it would be like
meeting the Messiah, if tobacco could save lives” (Participant
1). There was a recognition that PMF could provide a more
economically sustainable future for tobacco as the demand for
cigarettes “decreased.” Some participants also expressed a desire
to continue growing tobacco: “. . . anything that helps us continue
doing what we have done all our lives, would be fabulous”
(Participant 6).
There was also a perception that PMF tobacco could
improve the image of tobacco producers in the eyes of the
public, thus challenging the social stigma they felt. However,
discussion centered on the potential economic returns of PMF:
“It is important there is remuneration, an economic return. . .”
(Participant 22). Likewise, technicians expressed concern over
what new agronomic demands the crop might have and what
new infrastructure might be required – the regulatory status of
PMF crops was also questioned, with many participants familiar
with current EU legislation on biotechnology and reported the
fact that the genetic modification of tobacco had been resisted
by “Big Tobacco” in the past (see below). Some producers were
dismissive of hypothetical questions about PMF, expressing a
desire to instead work directly with new tobacco varieties: “There
is no sense talking about it now. If they decide to start, we’ll do a
trial . . . then we can talk directly to each other” (Participant 16).
Attitudes Toward NPBTs
In general, participants were not opposed to the use of NPBTs –
described to participants as genetic modification under current
EU law – and some producers in Spain had elected to grow GM
maize. For those expressing concerns about genetic modification,
perceptions of risk differed between PMF and other GM crops:
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“I mean, as a grower we have always been against [GM]. But
in this case, you understand, it is different. The product is
different” (Participant 16). A producer association representative
summarized the distinction as follows:
“. . . GM scares a bit, but what is the reason of this fear? For
its effect on human health. I mean, when you eat something,
yes, a food produced from GM plants, so you are worried about
the effect on your health. When the product is simply used to
extract some molecules... it doesn’t have a negative impact on that”
(Participant 18).
The distinction between food and non-food crops is
significant, but approval also rested on the purpose of PMF
as a beneficial alternative to smoking tobacco: “. . . something
that, with a gene change can improve health? I’d be delighted”
(Participant 5).
Most participants suspected the beneficial purpose of PMF
would lead to NPBTs being seen as more socially acceptable: “If
the product has a good purpose, why not?” (Participant 3). One,
however, used a local phrase (“ogni capa è ‘nu tribunale” or “every
head is a court”) to cast doubt on the extent to which public
reaction can be predicted. It was noted by some participants that
transgenic tobacco is banned in the EU.
The distinction between NPBTs and first-generation,
transgenic GM was discussed although some producers were
dismissive of such “scientific aspects,” having no concerns with
current GM crops or viewing the vertical gene transfer as being
equivalent to conventional hybridization. No ethical concerns
were raised, though one participant did claim that if animals
were being modified through the use of biotechnology, it was
by extension acceptable in plants. Several participants did see
an opportunity for more general agronomic improvements in
tobacco. The suppression of flowering was noted as being of
particular importance, as one Spanish grower explained: “We
[would] save 15, for sure 10 percent of the production costs. . .
less nitrogen and phosphates that they say we pour into the
rivers” (Participant 1).
Existing Supply Chain Actors and EU
Policy
Several elements of the existing systems that mediate modern
European tobacco production were cited as being important
for any new technological development in the sector. A high-
degree of trust was placed in the operation of the producer
associations (POs) – arranged as either businesses in their own
right or as farmer cooperatives – to which tobacco producers
must belong in order to maintain contracts with tobacco-buying
firms. As one producer noted: “It is a good association, we believe
in tobacco. . . and we hope to continue with this organization,
because otherwise, it they weren’t here everything would have
already stopped” (Participant 3). POs facilitate these contracts,
as well as providing necessary loans, equipment and agronomic
advice on varietal selection and pest management.
The “success” of PMF was considered to hinge on the support
of POs. The important role they play in farmer learning processes
is particularly relevant. Most producers received information
about new developments in the tobacco sector through their
BOX 1 | Selected questions generated by participants.
• Is PMF profitable?
• Have PMF crops ever been tested in the field?
• Why is the research team focussing on Europe and not elsewhere?
• Are there any Italian partners involved in the project?
• Are there any plans for PMF crops to be introduced in Spain?
• Are green (i.e., non-dried) or dried leaves needed to produce the desired
molecules?
• What quantities of tobacco are required?
• Will a new supply chain be required?
• What new infrastructure will be required?
• What technical progress has been made on the Newcotiana project?
PO (and technicians in particular): “Through [PO], we get lots
of good information” (Participant 8). The internet, agricultural
shows both at home and abroad and word of mouth were also
cited as important in this respect. The interconnectedness of
the European tobacco associations leads to the quick spread
of information: “Anything, any innovation in the world of
tobacco spills over to all other countries. And, of course, it’s a
well-structured group. We belong to cooperatives, those groups
have a professional body where all the processors and the
producers and everything at the new European level is connected”
(Participant 7).
There was a degree of uncertainty concerning the stance
of “Big Tobacco” – large tobacco-buying firms such as PMI,
the main buyer for most Spanish and Italian tobacco – toward
the prospect of PMF. Several participants suggested that such
firms could play a positive role in the development of the
technology. Others were somewhat suspicious of businesses that,
having considerable power in the tobacco supply chain, had
opposed the use of certain biotechnologies for tobacco in the
past, as one policy expert explained: “If they change their opinion
(because they change their opinion a lot), you have to be able
to adapt. Until now, they have not been in favor of this kind of
thing. And when there were talks about genetically modifying
tobacco, they never agreed” (Participant 4). The response of
the European Commission to the prospect of modified PMF
tobacco was also considered to be of paramount importance for
its development.
The questions that participants had for us as representatives
of the Newcotiana project are described in Box 1. These
are important because they provide examples of the
types of information that would be required for existing
tobacco producers and others to consider adopting these
technologies in future.
DISCUSSION
As Ferrell (2012) suggests, telling the “true” story of tobacco
farming is troublesome due to the stigma around the crop
and those who grow it. Tobacco farmers can be wary of
outsiders and outsiders themselves have strong, pre-formed
opinions of the sector. The Newcotiana project brings to this
stigmatized sector a likewise controversial form of plant breeding
(biotechnology). However, the findings above demonstrate a
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FIGURE 2 | Price of tobacco paid by first processor between 2007–2014 in Spain (flue, Virginia) and Italy (dark, Burley). The chart does not include agricultural
subsidies. Data derived from Raw Tobacco - Production Statistics - 2014 - 2003 Harvests (European Commission, 2015).
number of perceived risks and opportunities around new
technology. In the following section, these are discussed and
placed within a framework of barriers and facilitators to the
responsible scale-up of PMF in Europe.
Substitution of Tobacco
There are distinct parallels between the challenges faced by
European tobacco farmers and those facing their counterparts
in the United States: changing technologies, rising input costs,
stagnant or falling prices, labor shortages and pressure to expand
and/or diversify their operations (Ferrell, 2012). What data are
available to support these claims corroborate the picture of
challenging economic conditions for tobacco producers. The
price paid for tobacco in Europe by first processor remained
relatively stagnant between 2010 and 2014 at ∼€2 per kilogram
(more recent data are yet to be published), suggesting that any
increases in costs must be absorbed by cost-cutting measures
elsewhere (see Figure 2). Stagnating prices may explain why
producer concerns about PMF are predominantly economic
(Nevitt et al., 2003). As noted earlier, the EU has encouraged
tobacco substitution by decoupling subsidies from production
(Geist et al., 2009), although the decisions of individual members
states – as in Spain – have preserved tobacco cultivation
even where this has become economically questionable. Our
participants perceived PMF as a distinct opportunity to continue
with tobacco and remain profitable longer-term. In a study of 145
tobacco farmers in five US states, economic incentives prove a
key factor for the adoption of PMF tobacco (though increased
returns are required to match requirements for new equipment
and changes in production methods) (Hayes et al., 2014).
Finding workers was also cited as a problem by participants
and, as Geist et al. (2009) show, this extends to northern Europe
where recruitment and cost of labor pose significant problems.
However, Italy and Spain report the highest dependence on non-
family, non-regular agricultural workers in Europe (European
Union, 2017). Although the importance of maintaining rural
livelihoods is often invoked by tobacco-based firms as a reason to
avoid further tobacco control (or the promotion of substitution
for other crops) (Leppan et al., 2014), few studies have quantified
the impact of substitution on rural livelihoods. Research in
the Spanish context has found that labor requirements in
Extremadura would fall between 14.1 and 42.8% in various
tobacco substitution scenarios, demonstrating these concerns are
at least partially justified (Kienle et al., 2015). PMF tobacco could
bolster farm incomes providing a premium is guaranteed, but it
could also decrease reliance on labor (depending on condition of
leaf required and suppression of flowering time).
Our research suggests that small-scale, partial substitution of
smoking tobacco for PMF tobacco is the most likely first step in
any future transition. This aligns with existing research, in which
most farmers saw PMF tobacco as opportunity to complement
their existing crop portfolio, with only 15.4% willing to grow PMF
tobacco on more than 31% of their acreages (Nevitt et al., 2003).
Not only would partial substitution satisfy a desire that
many participants had to continue growing tobacco, there is
also opportunity to make use of farmers’ existing knowledge
and competencies. It would also represent tobacco production
“parallel” to (but not necessarily intersecting) traditional
tobacco farming (Nevitt et al., 2003). This would ensure
existing commercial relationships continue – mitigating risk for
producers – and preserving the structure and purpose of POs so
that they can help facilitate the development of PMF (see below).
The producers we spoke with were confident in their abilities
to produce a high-quality crop to specification. However, the
expressed desire by participants to first trial new varieties of
tobacco indicates that a period of experimentation will be
required; some producers mentioned having an area of their land
given over to such field trials and it would be likely that these
would form the first test beds for any new varieties. Importantly,
most farmers were not deterred by potential co-existence policies
for PMF tobacco, such as fallow zones between fields and 1-year
restrictions on growing non-PMF crops on land previously used
for modified tobacco. Such co-existence policies are currently
in force for the EU’s only approved GM crop varieties (maize),
which specify that these crops must be isolated from non-GM
cropping systems. Some form of isolation distance is expected
for PMF tobacco (Elbehri, 2005), though Herrero et al. (2017)
suggest that in Spain such measures are not enforced and have led
to social conflict between farmers of different production systems.
Existing research on tobacco substitution has found a range
of personal (farm-level) and systemic factors that can influence
such transitions. Many of these are action research projects
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in low-income countries in which researchers are embedded
in tobacco-growing communities – such a model may also be
of interest for PMF researchers in the future. Akhter et al.
(2014) employed an action research approach to instigate change
in tobacco growing communities in Bangladesh. Their study
found that supporting tobacco producers in diversifying their
crop portfolio facilitated the transition away from tobacco,
reinforcing the notion that producers with experience in growing
other crops are most likely to be willing to experiment with
new varieties. The majority of producers represented in our
sample have diversified their crop portfolios, suggesting a level
of willingness amongst Spanish and Italian growers to at least
experiment with new cops.
The Role of Producer Associations in the
Transition to PMF
Our participants also had concerns about the implications of
PMF for new agronomic practices and infrastructure. These
concerns are important; the willingness of farmers to switch to
biopharmaceutical tobacco has been shown to decrease as the
need for new production methods and equipment increases –
economic returns have to scale with these demands (Nevitt
et al., 2003; Hayes et al., 2014). Nevitt et al. (2003) suggest that
multi-season contracts would be required for tobacco farmers
to invest in new equipment for PMF if required. However, our
findings show that the demands of new production methods
or equipment may be counterbalanced by the simplification of
other processes, such as the suppression of flowering and/or
the use of “green” rather than dried tobacco leaf (two processes
that require significant time and money to manage). Other
studies of European farmers showed a similar willingness to
grow GM (food) crops providing that higher incomes and weed
control were guaranteed (Areal et al., 2011); additional steps
to ensure GM and non-GM crop co-existence policies were
adhered to diminished this willingness, however. It is not clear
whether the lack of tobacco wild relatives in Europe will lead
to more lenience with respect to EU GM coexistence policies
and distance-based planting for any potential future release of
PMF plants (despite this being promoted as an advantage for
certain PMF platforms). Spok and Karner (2008) note that even
greater isolation ranges could be required for biopharmaceuticals
due to the production of pharmaceutically active compounds,
constituting a risk for the development of PMF in regions where
smoking tobacco is grown.
Another risk for PMF is that the expected premiums for
products do not compensate for the extra demands of these
new tobacco varieties (including potential isolation distances) or
required downstream processes. However, there is a concomitant
opportunity for producer associations to help their members
adopt new agricultural technologies. The importance of POs
to the agricultural innovation processes has been somewhat
overlooked (Menary et al., 2019), but our findings suggest that
POs could play a vital role in the transition to PMF tobacco.
In addition to providing their members with agronomic advice,
contracts and loans of equipment and money, POs are trusted
by their members and can also access EU rural development
funding that single farmers cannot. The communal tobacco leaf-
drying facilities in Extremadura were funded in such a way. The
construction of contained facilities to grow PMF tobacco under
license (in absence of more favorable EU regulation toward GM
crops) could also be a possibility for these organizations. POs
can also facilitate contractual agreements between growers and
processors of PMF products, which suggests that those interested
in taking PMF beyond contained facilities should first interface
with such organizations.
Likewise, Unitab, a European-wide “association of
associations” that lobbies EU institutions on behalf of its
members and which was mentioned by several participants,
could represent a higher-level intervention point for the
promotion of PMF. There are a number of risks to this approach,
however. The first is that these organizations may not perceive
any value in new uses for tobacco – our own attempts to contact
various POs had mixed success. The second risk is that the
structure of the industry, with political and economic power
concentrated in large, influential businesses, could make POs
hesitant to support the development of new technologies seen
to challenge the status quo. PMF already faces some challenges
due to the technological “lock-in” of existing protein expression
systems (e.g., prior legislation that favors cell culture technology
and not plants and sunk investments in those systems) (Menary
et al., 2020). Those companies explicitly opposed to genetic
modification at this time – Imperial Brands (Our Views –
Imperial Brands, 2019), British American Tobacco (British
American Tobacco – Leaf research, 2019), and Altria Group
(Altria Group, 2016) – may therefore perceive PMF as a
contaminant threat to their non-GM crops, if not also a threat to
the availability of growers themselves (Nevitt et al., 2003)4. This
could pose a barrier to PMF at some point in the future. Despite
claims to the contrary, we were unable to find tobacco-specific
laws concerning genetic modification in the EU.
Stakeholder Attitudes Toward PMF and
NPBTs
Our findings describe (predominantly) favorable views toward
PMF and NPBTs amongst our participants. These views appear
to be driven in large part by the beneficial purpose of PMF,
which outweighed the perceived risk of genetic modification for
those few farmers who expressed concerns about GM food; some
participants also assumed this would hold true for the general
public. There is some evidence to suggest that the field of purpose
is important for the social acceptability of plant biotechnology,
health-related purposes being cited as more acceptable than
ornamental purposes, for example (Connor and Siegrist, 2010).
Our findings support the hypothesis that third-generation
biotechnology is more socially acceptable, at least for key
stakeholders. It has also been suggested that whereas the benefits
of first-generation biotechnology accrued to producers and seed
companies, second- and third-generation GM crops offer distinct
benefits to consumers and could change consumer opinion about
biotechnology (Sakakibara and Saito, 2006; Moses and Goossens,
4Philip Morris International do not state a position toward genetic modification
on their corporate website.
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2017). These factors, combined with the potential for cisgenic
or intragenic germlines, suggests that NPBT-bred tobacco for
medical use is more likely to be socially acceptable than previous
biotechnology applications.
Few environmental or ethical concerns were raised by
participants with respect to NPBTs. As Thompson (2007) notes,
these two factors have tended to be separated, environmental
risk being treated primarily as a technical issue unrelated
to ethics [though some authors have argued there is an
environmental cost to not adopting biotechnology (Biden et al.,
2018)]. Our participants did not cite either as significant areas
of perceived risk.
Reflections, Limitations, and Areas for
Further Inquiry
Stilgoe et al. (2013) notes that scientists have political
responsibility for new technology, as new technologies actively
shape society. Our approach has been to take account of
the potential synergies and obstacles with current tobacco
production. These findings will be communicated with the
Newcotiana consortium in order for scientists and others to
understand how PMF can be responsibly scaled-up in Europe.
However, a limitation of our approach is that the voices of
other potential stakeholders have not been heard. Some people
may resist any and all forms of genetic modification, such as
organic farmers in Spain (Herrero et al., 2017). Although we did
not limit contact to organizations with favorable views toward
PMF or GMOs, groups with negative views may have excluded
themselves from this study due to their reluctance to be associated
with the technology (indeed, this was the reason cited by one
tobacco producer association for avoiding involvement in the
study). Another limitation is that due to the early stage of open-
field tobacco development, important questions are unanswered:
exact quantities of crop required, expected price for a given
amount of tobacco and whether green or dried leaves (or a
combination) are needed.
There is also a challenge in balancing the need to provide
participants in such studies with enough information to ensure an
informed debate, but without influencing participants by “over-
framing” issues (Pidgeon et al., 2013). An area for further enquiry
may be to more robustly assess participants’ knowledge of genetic
modification techniques. If and when open-field PMF tobacco
varieties become commercially available, a follow-up study –
perhaps employing an action research approach – exploring how
the technology is deployed and adapted would be of interest to
agricultural technology adoption researchers.
CONCLUSION
Given the stagnating production of and prices for tobacco in EU
member states, the potential to incorporate PMF tobacco was
seen as favorable by key stakeholders. The possibility for tobacco
farming to become de-stigmatized – or at least, reduction of the
stigma of tobacco production – with a new purpose for tobacco as
a crop to produce important components for medicinal products,
was also viewed favorably by current tobacco producers. There
remain several unknowns: the attitudes of “big tobacco” toward
PMF tobacco, as well as the need for additional infrastructure and
potential profitability, were seen as potential risks to the scale-up
of PMF tobacco. Our research suggests that close collaboration
with these stakeholder groups – particularly POs, who have
connections to farmers as well as purchasers – has the potential
to identify and become an essential aspect for successful scale-up.
Importantly, we have demonstrated that there is demand
for at least certain types of biotechnology amongst particular
agricultural communities in the European Union. This may
indicate an imbalance between current policy and stakeholder
interest in these technologies.
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